Literature DB >> 921062

Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol in asthmatics.

S Larsson, N Svedmyr.   

Abstract

Effects and side effects of an adrenergic beta2-stimulant (salbutamol) given by mouth and by inhalation from a metered aerosol were compared. Cumulative dose-response curves for both routes of administration concerning 1-sec forced expiratory volume, forced vital capacity, heart rate, blood pressure, and tremor were constructed. Tremor was found to be the dose-limiting side effect with both modes of administration. The metered aerosol in doses as large as 0.6 mg was shown to produce a greater increase in the 1-sec forced expiratory volume, with fewer side effects than could be achieved with tolerable doses of salbutamol by mouth. An oral dose of 6 mg is probably the maximal tolerable dose in most cases. Oral treatment seems to have a better effect than inhalation treatment on the forced vital capacity at the same effect on 1-sec forced expiratory volume, possibly due to a better effect on small peripheral airways. The effect of combining different oral doses of salbutamol with inhaled salbutamol was also studied. A very good additional effect of inhalations given after 4 and 6 mg by mouth was shown.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 921062     DOI: 10.1164/arrd.1977.116.5.861

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  32 in total

1.  Comparison of the efficacy and systemic effects of 4 mg and 8 mg formulations of salbutamol controlled release in patients with asthma.

Authors:  B J Lipworth; R A Clark; D P Dhillon; J B Palmer; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 2.  Lower airway obstruction in the PICU.

Authors:  S A Kecskes
Journal:  Indian J Pediatr       Date:  1990 Mar-Apr       Impact factor: 1.967

3.  Current issues with beta2-adrenoceptor agonists: historical background.

Authors:  Anne E Tattersfield
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

4.  Short-term effects of inhaled salbutamol on autonomic cardiovascular control in healthy subjects: a placebo-controlled study.

Authors:  Leyla Cekici; Arschang Valipour; Robab Kohansal; Otto Chris Burghuber
Journal:  Br J Clin Pharmacol       Date:  2009-04       Impact factor: 4.335

5.  A new baby-spacer device for aerosolized bronchodilator administration in infants with bronchopulmonary disease.

Authors:  R Kraemer; P Birrer; K Modelska; C C Aebischer; M H Schöni
Journal:  Eur J Pediatr       Date:  1992-01       Impact factor: 3.183

6.  Dosage and delivery of nebulised beta agonists in hospital.

Authors:  J N Stainforth; R A Lewis; A E Tattersfield
Journal:  Thorax       Date:  1983-10       Impact factor: 9.139

7.  Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group.

Authors:  B Lundback; D W Rawlinson; J B Palmer
Journal:  Thorax       Date:  1993-02       Impact factor: 9.139

Review 8.  Combination bronchodilator therapy.

Authors:  G M Shenfield
Journal:  Drugs       Date:  1982-11       Impact factor: 9.546

Review 9.  Treatment of chronic obstructive pulmonary disease in older patients: a practical guide.

Authors:  Abebaw M Yohannes; Christopher C Hardy
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Classification of beta-adrenoceptors in human isolated bronchus.

Authors:  R G Goldie; J W Paterson; D Spina; J L Wale
Journal:  Br J Pharmacol       Date:  1984-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.